Loss of two new loci on chromosome 8 (8p23 and 8q12-13) in human prostate cancer

International Journal of Oncology

Volumn 14, Issue 3, 1999, Pages 495-500

  Perinchery, Geetha ^a   Bukurov, Nikola ^a   Nakajima, Koichi ^a   Chang, James ^a   Hooda, Madhu ^a   Oh, Bong Ryoul ^a   Dahiya, Rajvir ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Loss of heterozygosity; Prostate cancer; Tumor suppressor genes

Indexed keywords

MICROSATELLITE DNA;

ARTICLE; CHROMOSOME 8; CHROMOSOME MAP; GENETIC POLYMORPHISM; GENETICS; HETEROZYGOSITY LOSS; HUMAN; MALE; POLYMERASE CHAIN REACTION; PROSTATE TUMOR; TUMOR SUPPRESSOR GENE;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 8; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS;

EID: 0033094199     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.3.495     Document Type: Article

References (28)

1. Fujiwara Y, Emi M, Ohata H, Kato Y, Nakajima T, Mori T and Nakamura Y: Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma. Cancer Res 53: 1172-1174, 1993.
2. Keranugueven F, Essioux L, Dib A, Noguchi T, Allione F, Geneix G, Longy M and Lidereau R: Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8. Oncogene 10: 1023-1026, 1995.
3. Dahiya R, Perinchery G, Deng G and Lee C: Multiple sites of loss of heterozygosity on chromosome 8 in human breast cancer has differential correlation with clinical parameters. Int J Oncol 12: 811-816, 1998.
4. Emi M, Fujiwara Y, Nakajima T, Tsukiya E, Tsuda H, Hirohashi S, Maeda Y, Tsuruta K, Miyaki M and Nakamura Y: Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer and lung cancer. Cancer Res 52: 5368-5372, 1992.
5. Crundwell M, Chughtal S, Knowles M, Takle L, Luscombe M, Neoptolemos JP, Morton DG and Phillips SM: Allelic loss on chromosome 8p, 22q and 18q (DCC) in human prostate cancer. Int J Cancer 69: 295-300, 1996.
6. Kagan J, Stein J, Babaian RJ, Joe Y-S, Pisters L, Glassman AB, von Eschenbach AC and Troncoso P: Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes. Oncogene 11: 2121-2126, 1995.
7. Bova GS, Carter BS, Bussemakers MJ, Emi M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson JC, Epstein JI and Walsh PC: Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 53: 3869-3873, 1993.
8. Macoska JA, Trybus TM, Sakr WA, Wolf MC, Benson PD, Powell IJ and Pontes JE: Fluorescence in situ hydridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res 54: 3824-3830, 1994.
9. Matsuyama H, Pan Y, Skoog L, Tribukait B, Naito K, Ekman P, Lichter P and Bergerheim USR: Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization. Oncogene 9: 3071-3076, 1994.
10. Sakr WA, Macoska JA, Benson P, Grifnon DJ, Wolman SR, Pontes JE and Crissman JD: Allelic loss in locally metastatic, multisamples prostate cancer. Cancer Res 54: 3273-3277, 1994.
11. Vocke CD, Pozzatti RO, Bostwick DG, Florence CD, Jennings SB, Strup SE, Duray PH, Liotta LA, Emmer-Buck MR and Linehan WM: Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-22. Cancer Res 56: 2411-2416, 1996.
12. Cunningham JM, Shan A, Wick MJ, McDonnell SK, Schaid DJ, Tester DJ, Qian J, Takahashi S, Jenkins RB, Bostwick DG and Thibodeau SN: Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Res 56: 4475-4482, 1996.
13. Voeller HJ, Augustus M, Madike V, Kenneth SB, Carter KC and Gelmann EP: Coding region of NKX31, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers. Cancer Res 57: 4455-4459, 1997.
14. Cheng L, Song S-Y, Pretlow TG, Abdul-Karim FW, Kung H-J, Dawson DV, Park W-S, Moon Y-W, Tsai M-L, Linehan WM, Emmert-Buck MR, Liotta LA and Zhuang Z: Evidence of independent origin of multiple tumors from patients with prostate cancer. J Natl Cancer Inst 90: 233-237, 1998.
15. Emmert-Buck MR, Vocke CD, Pozzatti RO, Duray PH, Jennings SB, Florence CD, Zhuang Z, Bostwick DG, Liotta LA and Linehan WM: Allelic loss of chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res 55:2959-2962, 1995.
16. Trapman J, Sleddens HFBM, van der Weiden MM, Dinjens WNM, Konig JJ, Schroder FH, Faber PW and Bosman FT: Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Cancer Res 54: 6061-6064, 1994.
17. Dahiya R, McCarville J, Lee C, Hu W-X, Chui RM, Kaur G and Deng G: Chromosome 3p24-26 and 3p22-12 loss in human prostatic adenocarcinoma. Int J Cancer 71: 20-25, 1997.
18. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murpree AL, Strong LC and White RL: Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305: 779-784, 1983.
19. Lundgren R, Mandahl N, Heim S, Limon J, Henrikson H and Mitelman F: Cytogenctic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosomes Cancer 4: 16-24, 1992.
20. Bergerheim US, Kunimi K, Collins VP and Ekman P: Deletion mapping of chromosome 8, 10 and 16 in human prostatic carcinoma. Genes Chromosomes Cancer 3: 215-220, 1993.
21. Macoska JA, Micale MA, Sakr WA, Benson PD and Wolman SR: Extensive genetic alterations in prostate cancer revealed by dual PCR and FISH analysis. Genes Chromosomes Cancer 8: 88-97, 1993.
22. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y and White R: Allelotype of colorectal carcinomas. Science 244: 207-211, 1989.
23. Cunningham C, Dunlop MG, Wyllie AH and Bird CC: Deletion mapping in colorectal carcinoma of a putative tumor suppressor gene in 8p22-8p213. Oncogene 8: 1391-1396, 1993.
24. Knowles MA, Shaw ME and Proctor AJ: Deletion mapping of chromosome 8 in cancers of the urinary bladder using RFLPs and microsatellite polymorphisms. Oncogene 8: 1357-1364, 1993.
25. Alers JC, Krijtenburg PJ, Rosenberg C, Hop WC, Verkerk AM, Schroder FH, van der Kwast TH, Bosman FT and Dekken H: Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone. Lab Invest 77: 437-448, 1997.
26. Jenkins R, Takahashi S, De Lacey K, Berstralh E and Lieber M: Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer. Genes Chromosomes Cancer 21: 131-143, 1998.
27. Ichikawa T, Nihei N, Suzuki H, Oshima M, Emi M, Nakamura Y, Hayata I, Isaacs JT and Shimazaki J: Suppression of metastasis of rat prostatic cancer by introducing human chromosome 8. Cancer Res 54: 2299-2302, 1994.
28. Reiter RE, Gu Z, Watabe T, Thomas G, Szigeti K, Davis E, Wahl M, Nisitani S, Yamashiro J, Le Beau MM, Loda M and Witte ON: Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci USA 95: 1735-1740, 1998.